CROX - Crocs, Inc.
NASDAQ
->
Consumer Cyclical
->
Footwear & Accessories
Broomfield,
United States
Type: Equity
CROX price evolution
CROX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $171.03 | $163.02 | $153.1 | |
| Short term investments | ||||
| Net receivables | $386.18 | $440.48 | $510.85 | $326.82 |
| Inventory | $367.19 | $376.6 | $391.95 | $385.05 |
| Total current assets | $990.42 | $1026.9 | $1106.4 | $910.7 |
| Long term investments | ||||
| Property, plant & equipment | $547.12 | $536.16 | $523.04 | $525.75 |
| Goodwill & intangible assets | $2496.84 | $2499.15 | $2504.15 | |
| Total noncurrent assets | $3692.89 | $3689.21 | $3733.13 | |
| Total investments | ||||
| Total assets | $4713.15 | $4719.8 | $4795.6 | $4643.83 |
| Current liabilities | ||||
| Accounts payable | $240.89 | $244.85 | $236.29 | $260.98 |
| Deferred revenue | ||||
| Short long term debt | $63.92 | $62.76 | $85.59 | |
| Total current liabilities | $692.53 | $686.42 | $628.56 | $698.3 |
| Long term debt | $1421.95 | $1806.68 | $1727.15 | $1910.77 |
| Total noncurrent liabilities | $2380.17 | $2569.99 | $2491.61 | |
| Total debt | $1870.6 | $2057.7 | $1996.36 | |
| Total liabilities | $2988.03 | $3066.59 | $3198.55 | $3189.91 |
| Shareholders' equity | ||||
| Retained earnings | $3192.93 | $2993.13 | $2764.22 | $2611.76 |
| Other shareholder equity | -$92.95 | -$113.33 | -$106.92 | -$95.77 |
| Total shareholder equity | $1653.21 | $1597.06 | $1453.92 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $153.1 | $194.88 | $216.93 | $139.27 |
| Short term investments | ||||
| Net receivables | $326.82 | $329.19 | $194.88 | $160.66 |
| Inventory | $385.05 | $471.55 | $213.52 | $175.12 |
| Total current assets | $910.7 | $1025.97 | $666.57 | $492.84 |
| Long term investments | ||||
| Property, plant & equipment | $525.75 | $421.43 | $269.17 | $224.89 |
| Goodwill & intangible assets | $2504.15 | $2514.98 | $30.4 | $39.35 |
| Total noncurrent assets | $3733.13 | $3475.82 | $878.5 | $625.88 |
| Total investments | ||||
| Total assets | $4643.83 | $4501.8 | $1545.07 | $1118.72 |
| Current liabilities | ||||
| Accounts payable | $260.98 | $230.82 | $162.15 | $112.78 |
| Deferred revenue | ||||
| Short long term debt | $85.59 | $81.82 | $42.93 | $47.06 |
| Total current liabilities | $698.3 | $641.27 | $388.24 | $291.58 |
| Long term debt | $1910.77 | $2298.03 | $920.63 | $326.4 |
| Total noncurrent liabilities | $2491.61 | $3042.59 | $1142.74 | $536.51 |
| Total debt | $1996.36 | $2594.96 | $963.56 | $373.46 |
| Total liabilities | $3189.91 | $3683.87 | $1530.99 | $828.09 |
| Shareholders' equity | ||||
| Retained earnings | $2611.76 | $1819.2 | $1279.04 | $553.35 |
| Other shareholder equity | -$95.77 | -$103.49 | -$76.84 | -$56.35 |
| Total shareholder equity | $1453.92 | $817.93 | $14.08 | $290.63 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1062.2 | $1111.5 | $938.63 | $960.1 |
| Cost of revenue | $429.59 | $416.56 | $429.4 | |
| Gross Profit | $633.34 | $681.92 | $522.08 | $530.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $356.18 | $295.65 | $311.9 | |
| Total operating expenses | $363.51 | $356.18 | $295.65 | $321.18 |
| Operating income | $325.74 | $226.43 | $209.51 | |
| Income from continuing operations | ||||
| EBIT | $325.59 | $224.59 | $210.3 | |
| Income tax expense | $45.1 | $67.52 | $41.58 | -$79.73 |
| Interest expense | -$25.17 | $29.16 | $30.56 | $36.44 |
| Net income | ||||
| Net income | $199.8 | $228.91 | $152.45 | $253.59 |
| Income (for common shares) | $228.91 | $152.45 | $253.59 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3962.35 | $3554.99 | $2313.42 | $1385.95 |
| Cost of revenue | $1752.34 | $1694.7 | $893.2 | $636 |
| Gross Profit | $2210.01 | $1860.28 | $1420.22 | $749.95 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1163.94 | $1009.53 | $737.16 | $514.75 |
| Total operating expenses | $1173.23 | $1009.53 | $737.16 | $535.82 |
| Operating income | $1036.78 | $850.76 | $683.06 | $214.12 |
| Income from continuing operations | ||||
| EBIT | $1037.62 | $854.67 | $685.5 | $213.72 |
| Income tax expense | $83.71 | $178.35 | -$61.84 | -$105.88 |
| Interest expense | $161.35 | $136.16 | $21.65 | $6.74 |
| Net income | ||||
| Net income | $792.57 | $540.16 | $725.69 | $312.86 |
| Income (for common shares) | $792.57 | $540.16 | $725.69 | $312.86 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $228.91 | $152.45 | $253.59 | |
| Operating activities | ||||
| Depreciation | $17.54 | $16.16 | $13.77 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $10.16 | $7.58 | $5.57 | |
| Total cash flows from operations | $401.24 | -$27.57 | $349.72 | |
| Investing activities | ||||
| Capital expenditures | -$17.06 | -$15.75 | -$29.25 | |
| Investments | ||||
| Total cash flows from investing | -$50.86 | -$17.06 | -$15.75 | -$29.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$175.01 | -$5.91 | -$25.06 | |
| Net borrowings | -$200 | $61.75 | -$276.73 | |
| Total cash flows from financing | -$583.67 | -$375.01 | $54.83 | -$301.79 |
| Effect of exchange rate | $0.43 | -$1.17 | -$1.58 | $3.34 |
| Change in cash and equivalents | $36.45 | $8.01 | $9.93 | $22.07 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $792.57 | $540.16 | $725.69 | $312.86 |
| Operating activities | ||||
| Depreciation | $54.3 | $39.23 | $31.98 | $27.62 |
| Business acquisitions & disposals | -$2046.88 | |||
| Stock-based compensation | $29.07 | $31.3 | $38.12 | $16.36 |
| Total cash flows from operations | $930.44 | $603.14 | $567.16 | $266.9 |
| Investing activities | ||||
| Capital expenditures | -$115.63 | -$104.19 | -$55.91 | -$41.57 |
| Investments | ||||
| Total cash flows from investing | -$115.67 | -$2151.09 | -$55.92 | -$41.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$192.1 | -$11.48 | -$1020.12 | -$170.83 |
| Net borrowings | -$665.8 | $1594.61 | $605 | -$25 |
| Total cash flows from financing | -$859.64 | $1529.66 | -$429.64 | -$198.04 |
| Effect of exchange rate | $3.08 | -$3.75 | -$3.95 | $0.13 |
| Change in cash and equivalents | -$41.79 | -$22.04 | $77.65 | $27.23 |
News
Fundamentals
| Market cap | $6.54B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 58.50M |
| Revenue | $4.07B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $834.75M |
| Revenue Q/Q | 1.58% |
| Revenue Y/Y | 3.17% |
| P/E ratio | 7.84 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.61 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $14.27 |
|---|---|
| ROA | 17.69% |
| ROE | N/A |
| Debt/Equity | 2.19 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.43 |
| Quick ratio | 0.90 |